1565
287
97
94
85
82
74
67
61
56
52
48
40
38
38
37
33
32
32
31
31
29
24
23
23
22
20
20
19
19
18
17
17
16
16
16
16
15
15
14
12
12
12
12
11
11
10
10
9
9
9
9
9
8
8
8
8
7
7
7
7
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
12239
1223
2769
276
3149
314
J CLIN ONCOL
RAINBOW-Asia: A randomized, multicenter, double-blind, phase III study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in the treatment of advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma following disease progression on first-line chemotherapy with platinum and fluoropyrimidine
PDF的下载单位、IP信息已删除
(2025-6-4)